3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Breast
1
Conditions
Ovarian Neoplasms
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Fallopian Tube Neoplasms
3
Advanced Ovarian Cancer
3
Uterine Neoplasms
2
Uterine Cervical Neoplasms
2
Pain, Postoperative
2
Vomiting
1
Thromboembolism
1
Primary Peritoneal Neoplasm
1
Postoperative Hemorrhage
1
Peritoneal Neoplasms
1
Peripheral Nervous System Diseases
1
Pelvic Neoplasms
1
Neoplasm Metastasis
1
Myofibroma
1
Disease Progression
1
Carcinoma, Ovarian Epithelial
1
Blood Loss, Surgical
1
Interventions
Paclitaxel
2
sagopilone
1
allantoicase
1
Vitamin B Complex
1
Sodium Selenite
1
Sodium Chloride
1
Saline Solution
1
Prednisolone
1
Physical Therapy Modalities
1
Omacor
1
Low-Level Light Therapy
1
Fish Oils
1
Fatty Acids, Omega-3
1
Drug Therapy
1
Carboplatin
1
Bevacizumab
1
BID protein, human
1
Amifostine
1
Acetylcarnitine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Peripheral Nervous System Diseases
×
Saline Solution
×
Gynecologic
×
Clear all
NCT04201561
2023-06-26
SELENIUM
Seoul National University Hospital
Phase 3
Unknown
68 enrolled